Rohan Manohar is a translational sciences researcher and cross-functional project leader with over 10 years of biopharmaceutical experience, specializing in metabolic diseases and drug development. Rohan has contributed to various roles, including a Research Scientist at Gilead Sciences, where they developed assays for drug evaluation, and as a Principal Scientist at Takeda. Rohan holds a PhD in Pathology from the University of Pittsburgh and a Bachelor of Science in Biology and Chemistry from Denison University. Currently, Rohan serves as the Director of Cardiometabolic Diseases and Obesity at Valo Health, leading initiatives in AI-enabled drug discovery and translational research.
This person is not in any teams
This person is not in any offices